Search research articles
Contact Us
Filters
Showing results (161-170 of 172) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Malignant melanoma and renal cell carcinoma: immunological and haematological effects of recombinant human interleukin-2
K Hayat, S Rodgers, L Bruce, et al.
British Journal of Cancer
|
January 1, 1994
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
F C Hamdy, E J Fadlon, D Cottam, et al.
Bioinformatics (Oxford, England)
|
April 6, 2002
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers
G Ball, S Mian, F Holding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 12, 1995
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15
J A Johnston, C M Bacon, D S Finbloom, et al.
British Journal of Cancer
|
April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
T M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer
M E Boursnell, C Entwisle, S A Ali, et al.
International Journal of Cancer
|
June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomas
K A Mulcahy, D Rimoldi, F Brasseur, et al.
Oncogene
|
November 10, 2015
Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer
M E Buczek, A K Miles, W Green, et al.
Cancer Research
|
April 5, 2000
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes
S A Ali, C S McLean, M E Boursnell, et al.
Breast Cancer Research and Treatment
|
April 7, 2009
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks
L J Lancashire, D G Powe, J S Reis-Filho, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 172) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Malignant melanoma and renal cell carcinoma: immunological and haematological effects of recombinant human interleukin-2
K Hayat, S Rodgers, L Bruce, et al.
British Journal of Cancer
|
January 1, 1994
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
F C Hamdy, E J Fadlon, D Cottam, et al.
Bioinformatics (Oxford, England)
|
April 6, 2002
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers
G Ball, S Mian, F Holding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 12, 1995
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15
J A Johnston, C M Bacon, D S Finbloom, et al.
British Journal of Cancer
|
April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
T M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer
M E Boursnell, C Entwisle, S A Ali, et al.
International Journal of Cancer
|
June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomas
K A Mulcahy, D Rimoldi, F Brasseur, et al.
Oncogene
|
November 10, 2015
Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer
M E Buczek, A K Miles, W Green, et al.
Cancer Research
|
April 5, 2000
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes
S A Ali, C S McLean, M E Boursnell, et al.
Breast Cancer Research and Treatment
|
April 7, 2009
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks
L J Lancashire, D G Powe, J S Reis-Filho, et al.
Page
of 18